Current Protein Identity:P09242 New Search
Main Difference Dimensions in This Set
Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
10TV Tissue Non-specific Alkaline Phosphatase -S110A bound to phosphocreatine Deposited 2026-02-09 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: octameric(8) Review required
Chain A 17–501(485 aa)
Chain B 17–501(485 aa)
Chain C 17–501(485 aa)
Chain D 17–501(485 aa)
Mutation:S110A Mutation:S110A Mutation:S110A Mutation:S110A XDC Phosphocreatine × 4 ZN ZINC ION × 4 MG MAGNESIUM ION × 4 CA CALCIUM ION × 4 GOL GLYCEROL × 10 NA SODIUM ION × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 10 MAN alpha-D-mannopyranose × 1 PO4 PHOSPHATE ION × 3 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293.15 K;0.15 M phosphate/citrate pH 4.0, 0.2 M NaCl, 0-30 mM phosphate, 5% glycerol, 14-16% PEG 10,000
Resolution 2.26 Å R-free 0.216
10TW Tissue Non-specific Alkaline Phosphatase -D370G bound to phosphocreatine Deposited 2026-02-09 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 17–501(485 aa)
Chain B 17–501(485 aa)
Chain C 17–501(485 aa)
Chain D 17–501(485 aa)
Mutation:D370G Mutation:D370G Mutation:D370G Mutation:D370G PO4 PHOSPHATE ION × 4 ZN ZINC ION × 4 MG MAGNESIUM ION × 4 CA CALCIUM ION × 4 NA SODIUM ION × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 GOL GLYCEROL × 6 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293.15 K;0.15 M phosphate/citrate pH 4.0, 0.2 M NaCl, 0-30 mM phosphate, 5% glycerol, 14-16% PEG 10,000
Resolution 2.12 Å R-free 0.216
10TX Tissue Non-specific Alkaline Phosphatase -S110A bound to PPi Deposited 2026-02-09 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 17–501(485 aa)
Chain B 17–501(485 aa)
Chain C 17–501(485 aa)
Chain D 17–501(485 aa)
Mutation:S110A Mutation:S110A Mutation:S110A Mutation:S110A NA SODIUM ION × 4 POP PYROPHOSPHATE 2- × 4 ZN ZINC ION × 4 MG MAGNESIUM ION × 4 CA CALCIUM ION × 4 GOL GLYCEROL × 10 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 PO4 PHOSPHATE ION × 2 FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293.15 K;0.15 M phosphate/citrate pH 4.0, 0.2 M NaCl, 0-30 mM phosphate, 5% glycerol, 14-16% PEG 10,000
Resolution 2.25 Å R-free 0.232
10TY Tissue Non-specific Alkaline Phosphatase -S110A bound to PPi with ethylene glycol Deposited 2026-02-09 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 17–501(485 aa)
Chain B 17–501(485 aa)
Chain C 17–501(485 aa)
Chain D 17–501(485 aa)
Mutation:S110A Mutation:S110A Mutation:S110A Mutation:S110A POP PYROPHOSPHATE 2- × 4 ZN ZINC ION × 4 MG MAGNESIUM ION × 4 CA CALCIUM ION × 4 NA SODIUM ION × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 MAN alpha-D-mannopyranose × 1 PO4 PHOSPHATE ION × 2 FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293.15 K;0.15 M phosphate/citrate pH 4.0, 0.2 M NaCl, 0-30 mM phosphate, 14-16% PEG 10,000
Resolution 2.28 Å R-free 0.249
10TZ Tissue Non-specific Alkaline Phosphatase -S110A bound to ATP Deposited 2026-02-09 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 17–501(485 aa)
Chain B 17–501(485 aa)
Chain C 17–501(485 aa)
Chain D 17–501(485 aa)
Mutation:S110A Mutation:S110A Mutation:S110A Mutation:S110A ATP ADENOSINE-5'-TRIPHOSPHATE × 4 ZN ZINC ION × 4 MG MAGNESIUM ION × 3 CA CALCIUM ION × 4 GOL GLYCEROL × 10 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 FLC CITRATE ANION × 1 PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293.15 K;0.15 M phosphate/citrate pH 4.0, 0.2 M NaCl, 0-30 mM phosphate, 5% glycerol, 14-16% PEG 10,000
Resolution 2.71 Å R-free 0.310